Molecular imaging of hypoxia with radiolabelled agents

por Mees, Gilles, Dierckx, Rudi, Vangestel, Christel, Van de Wiele, Christophe
Publicado 2009

Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders—An Update

por Dewulf, Jonatan, Adhikari, Karuna, Vangestel, Christel, Wyngaert, Tim Van Den, Elvas, Filipe
Publicado en Cancers (Basel) (2020)

How to Modulate Tumor Hypoxia for Preclinical In Vivo Imaging Research

por De Bruycker, Sven, Vangestel, Christel, Staelens, Steven, Van den Wyngaert, Tim, Stroobants, Sigrid
Publicado en Contrast Media Mol Imaging (2018)

Characterization of [(99m)Tc]Duramycin as a SPECT Imaging Agent for Early Assessment of Tumor Apoptosis

por Elvas, Filipe, Vangestel, Christel, Rapic, Sara, Verhaeghe, Jeroen, Gray, Brian, Pak, Koon, Stroobants, Sigrid, Staelens, Steven, wyffels, Leonie
Publicado en Mol Imaging Biol (2015)

Early Changes in [(18)F]FDG Uptake as a Readout for PI3K/Akt/mTOR Targeted Drugs in HER-2-Positive Cancer Xenografts

por Dockx, Yanina, Vangestel, Christel, Van den Wyngaert, Tim, Huizing, Manon, De Bruycker, Sven, Pauwels, Patrick, Staelens, Steven, Stroobants, Sigrid
Publicado en Mol Imaging (2021)

Immuno-PET Molecular Imaging of RANKL in Cancer

por Dewulf, Jonatan, Vangestel, Christel, Verhoeven, Yannick, De Waele, Jorrit, Zwaenepoel, Karen, van Dam, Peter A., Elvas, Filipe, Van den Wyngaert, Tim
Publicado en Cancers (Basel) (2021)

Effects of metformin on tumor hypoxia and radiotherapy efficacy: a [(18)F]HX4 PET imaging study in colorectal cancer xenografts

por De Bruycker, Sven, Vangestel, Christel, Staelens, Steven, wyffels, Leonie, Detrez, Jan, Verschuuren, Marlies, De Vos, Winnok H., Pauwels, Patrick, Van den Wyngaert, Tim, Stroobants, Sigrid
Publicado en EJNMMI Res (2019)

Preclinical Evaluation of a Novel (18)F-Labeled dTCO-Amide Derivative for Bioorthogonal Pretargeted Positron Emission Tomography Imaging

por Ruivo, Eduardo, Elvas, Filipe, Adhikari, Karuna, Vangestel, Christel, Van Haesendonck, Glenn, Lemière, Filip, Staelens, Steven, Stroobants, Sigrid, Van der Veken, Pieter, wyffels, Leonie, Augustyns, Koen
Publicado en ACS Omega (2020)

Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors

por Vandamme, Timon, Beyens, Matthias, de Beeck, Ken Op, Dogan, Fadime, van Koetsveld, Peter M, Pauwels, Patrick, Mortier, Geert, Vangestel, Christel, de Herder, Wouter, Van Camp, Guy, Peeters, Marc, Hofland, Leo J
Publicado en Br J Cancer (2016)

Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy

por Jacobs, Julie, Deschoolmeester, Vanessa, Rolfo, Christian, Zwaenepoel, Karen, Van den Bossche, Jolien, Deben, Christophe, Silence, Karen, de Haard, Hans, Hermans, Christophe, Rottey, Sylvie, Vangestel, Christel, Lardon, Filip, Smits, Evelien, Pauwels, Patrick
Publicado en Oncotarget (2017)

Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA(5m) chelators

por Moon, Euy Sung, Elvas, Filipe, Vliegen, Gwendolyn, De Lombaerde, Stef, Vangestel, Christel, De Bruycker, Sven, Bracke, An, Eppard, Elisabeth, Greifenstein, Lukas, Klasen, Benedikt, Kramer, Vasko, Staelens, Steven, De Meester, Ingrid, Van der Veken, Pieter, Rösch, Frank
Publicado en EJNMMI Radiopharm Chem (2020)